Skip to main content

Peer Review reports

From: Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

Original Submission
3 Apr 2011 Submitted Original manuscript
22 Apr 2011 Reviewed Reviewer Report - Henry Simpkins
28 Apr 2011 Reviewed Reviewer Report - Robert Mandic
6 May 2011 Reviewed Reviewer Report - Steven de Jong
6 Jun 2011 Author responded Author comments - Ding Ma
Resubmission - Version 2
6 Jun 2011 Submitted Manuscript version 2
10 Jun 2011 Reviewed Reviewer Report - Henry Simpkins
22 Jun 2011 Reviewed Reviewer Report - Steven de Jong
25 Jun 2011 Reviewed Reviewer Report - Robert Mandic
12 Jul 2011 Author responded Author comments - Ding Ma
Resubmission - Version 3
12 Jul 2011 Submitted Manuscript version 3
24 Jul 2011 Author responded Author comments - Ding Ma
Resubmission - Version 4
24 Jul 2011 Submitted Manuscript version 4
7 Aug 2011 Author responded Author comments - Ding Ma
Resubmission - Version 5
7 Aug 2011 Submitted Manuscript version 5
8 Aug 2011 Author responded Author comments - Ding Ma
Resubmission - Version 6
8 Aug 2011 Submitted Manuscript version 6
1 Sep 2011 Author responded Author comments - Ding Ma
Resubmission - Version 7
1 Sep 2011 Submitted Manuscript version 7
13 Sep 2011 Author responded Author comments - Ding Ma
Resubmission - Version 8
13 Sep 2011 Submitted Manuscript version 8
Publishing
21 Sep 2011 Editorially accepted
21 Sep 2011 Article published 10.1186/1471-2407-11-399

You can find further information about peer review here.

Back to article page